account_num,net_change,tag,tag_depth,cik
3316,-64339911.0,StockholdersEquity,1,1325618_IRADIMED CORP
2149,-4349655.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,1325618_IRADIMED CORP
2130,-342409.0,NonoperatingIncomeExpense,1,1325618_IRADIMED CORP
1264,-4007246.0,OperatingIncomeLoss,1,1325618_IRADIMED CORP
2347,-4025810.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,1325618_IRADIMED CORP
3017,-250000.0,OtherLiabilitiesCurrent,2,1325618_IRADIMED CORP
3154,-6756121.0,LiabilitiesCurrent,2,1325618_IRADIMED CORP
3379,-1938424.0,OperatingLeaseLiabilityNoncurrent,3,1325618_IRADIMED CORP
3796,-4524003.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,1325618_IRADIMED CORP
1112,7714202.0,OperatingExpenses,1,1325618_IRADIMED CORP
3645,-4524003.0,LiabilitiesNoncurrent,2,1325618_IRADIMED CORP
3661,-1259.0,CommonStockValue,3,1325618_IRADIMED CORP
3750,-26891212.0,AdditionalPaidInCapital,1,1325618_IRADIMED CORP
3834,-37447440.0,RetainedEarningsAccumulatedDeficit,1,1325618_IRADIMED CORP
1002,-4894.0,GainLossOnDispositionOfAssets1,1,1325618_IRADIMED CORP
961,-4894.0,GainLossOnSaleOfPropertyPlantEquipment,1,1325618_IRADIMED CORP
692,180788.0,ProvisionForDoubtfulAccounts,2,1325618_IRADIMED CORP
601,6920486.0,SellingGeneralAndAdministrativeExpense,3,1325618_IRADIMED CORP
597,3920510.0,GeneralAndAdministrativeExpense,2,1325618_IRADIMED CORP
232,-11721448.0,GrossProfit,1,1325618_IRADIMED CORP
173,-15475083.0,Revenues,1,1325618_IRADIMED CORP
3917,-75620035.0,LiabilitiesAndStockholdersEquity,2,1325618_IRADIMED CORP
3260,-64339911.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,1325618_IRADIMED CORP
3465,-11280124.0,Liabilities,1,1325618_IRADIMED CORP
1368,8643485.0,PropertyPlantAndEquipmentNet,4,1325618_IRADIMED CORP
2089,75620035.0,Assets,1,1325618_IRADIMED CORP
2398,-1756177.0,AccountsPayableCurrent,2,1325618_IRADIMED CORP
645,42777158.0,CashAndCashEquivalentsAtCarryingValue,3,1325618_IRADIMED CORP
59,-341287.0,AllowanceForDoubtfulAccountsReceivableCurrent,3,1325618_IRADIMED CORP
229,11533214.0,AccountsReceivableNetCurrent,3,1325618_IRADIMED CORP
207,11533214.0,AccountsNotesAndLoansReceivableNetCurrent,4,1325618_IRADIMED CORP
320,11533214.0,ReceivablesNetCurrent,3,1325618_IRADIMED CORP
455,6312265.0,InventoryNet,2,1325618_IRADIMED CORP
260,6312265.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,1325618_IRADIMED CORP
677,254093.0,PrepaidExpenseCurrent,2,1325618_IRADIMED CORP
868,61298385.0,AssetsCurrent,2,1325618_IRADIMED CORP
1634,2347719.0,OperatingLeaseRightOfUseAsset,2,1325618_IRADIMED CORP
2257,-4349655.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,1325618_IRADIMED CORP
1732,2205287.0,IntangibleAssetsNetExcludingGoodwill,2,1325618_IRADIMED CORP
1827,2205287.0,IntangibleAssetsNetIncludingGoodwill,2,1325618_IRADIMED CORP
2041,502953.0,OtherAssetsNoncurrent,2,1325618_IRADIMED CORP
2091,14321650.0,AssetsNoncurrent,2,1325618_IRADIMED CORP
577,42777158.0,CashCashEquivalentsAndShortTermInvestments,4,1325618_IRADIMED CORP
2399,943589.0,IncomeTaxExpenseBenefit,1,1325618_IRADIMED CORP
2903,-3406066.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,1325618_IRADIMED CORP
1077,-3406066.0,ProfitLoss,2,1325618_IRADIMED CORP
2943,-101018.0,ProductWarrantyAccrualClassifiedCurrent,2,1325618_IRADIMED CORP
737,254093.0,PrepaidTaxes,1,1325618_IRADIMED CORP
1820,-5293244.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,1325618_IRADIMED CORP
2841,-551979.0,TaxesPayableCurrent,2,1325618_IRADIMED CORP
2877,-493392.0,AccruedIncomeTaxesCurrent,2,1325618_IRADIMED CORP
581,793716.0,OperatingCostsAndExpenses,2,1325618_IRADIMED CORP
491,793716.0,ResearchAndDevelopmentExpense,2,1325618_IRADIMED CORP
144,3753635.0,CostOfRevenue,1,1325618_IRADIMED CORP
2710,-2071016.0,DeferredRevenueCurrent,2,1325618_IRADIMED CORP
171,86690.0,CostOfGoodsAndServicesSold,2,1325618_IRADIMED CORP
3809,-6127.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,1325618_IRADIMED CORP
2552,-2269633.0,AccruedLiabilitiesCurrent,2,1325618_IRADIMED CORP
1901,622206.0,DeferredIncomeTaxAssetsNet,2,1325618_IRADIMED CORP
2590,-3406066.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,1325618_IRADIMED CORP
1912,-3406066.0,NetIncomeLoss,1,1325618_IRADIMED CORP
162,86690.0,CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization,6,1325618_IRADIMED CORP
2673,-1616636.0,EmployeeRelatedLiabilitiesCurrent,2,1325618_IRADIMED CORP
707,2999976.0,SellingAndMarketingExpense,2,1325618_IRADIMED CORP
1652,2205287.0,FiniteLivedIntangibleAssetsNet,2,1325618_IRADIMED CORP
3078,-58587.0,AccrualForTaxesOtherThanIncomeTaxesCurrent,2,1325618_IRADIMED CORP
795,86690.0,ProductionRelatedImpairmentsOrCharges,1,1325618_IRADIMED CORP
759,86690.0,InventoryWriteDown,1,1325618_IRADIMED CORP
2764,-2071016.0,ContractWithCustomerLiabilityCurrent,3,1325618_IRADIMED CORP
3279,-2585579.0,DeferredRevenueNoncurrent,2,1325618_IRADIMED CORP
3339,-2585579.0,ContractWithCustomerLiabilityNoncurrent,3,1325618_IRADIMED CORP
